Latest News and Press Releases

Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults with primary membranous nephropathy (PMN)There are currently no therapies...

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "IgA Nephropathy Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

Exton, Pennsylvania, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The FDA's recent approvals of Calliditas' Tarpeyo (budesonide) and Travere's Filspari (sparsentan) to treat primary IgA nephropathy (IgAN) have...

Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- The global diabetic nephropathy market size was valued at USD 2.38 billion in 2020. The market is estimated to rise from USD 2.49 billion in 2021 to...

New York, USA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), The Diabetic Nephropathy...

Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering. Diabetic nephropathy, also known as diabetic...

ROCKVILLE, Md., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Because many relatively unknown rare diseases can cause permanent damage to the kidneys, the American Kidney Fund (AKF) today announced it has...